Boston Scientific Corp (BSX) Key Ratios

$42.60

up-down-arrow $-0.63 (-1.46%)

As on 02-Oct-2026 16:19EDT

Market cap

info icon

$62,650 Mln

Revenue (TTM)

info icon

$20,996 Mln

P/E Ratio

info icon

17.6

P/B Ratio

info icon

2.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 4.59 7.53 13.53 16.15 13.40
EBIT -7.67 12.12 24.35 33.38 37.51
Net Profit -32.11 14.34 46.33 74.57 62.30
EPS -31.70 15.02 46.43 57.38 46.39
Book Value -- -- 10.90 9.96 8.77
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 16.8015.0120.1218.6015.94
Net Margin info --7.0617.47----
Return on equity info 10.078.1614.9412.559.03
Return on Capital info 6.685.35--8.306.01
Return on Assets info 5.554.427.456.954.98
Debt to Equity (x) info ----0.430.510.51
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
8.30
6.01
5.73
2.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

14.94

Higher than Peers by 9.97

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
14.94
12.55
9.03
8.64
4.08
Peer Median
4.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

7.45

Higher than Peers by 4.99

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
7.45
6.95
4.98
4.71
2.16
Peer Median
2.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

20.12

Higher than Peers by 11.36

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
20.12
18.60
15.94
15.85
12.66
Peer Median
8.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

17.47

Higher than Peers by 12.71

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
17.47
14.38
11.07
11.19
5.52
Peer Median
4.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

13.53

Higher than Peers by 4.93

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
13.53
0.20
0.18
0.12
0.07
Peer Median
8.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

24.35

Higher than Peers by 13.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
24.35
39.90
18.25
40.62
12.63
Peer Median
11.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

46.33

Higher than Peers by 33.00

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
46.33
55.66
16.38
128.22
-32.88
Peer Median
13.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

46.43

Higher than Peers by 26.35

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
46.43
0.55
0.15
1.23
-0.33
Peer Median
20.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

11.83

Higher than Peers by 4.76

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
11.83
--
--
--
--
Peer Median
7.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.43

Higher than Peers by 0.03

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
0.43
0.51
0.51
0.49
0.53
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.07

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
0.07
0.02
0.08
0.03
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.24

Lower than Peers by 1.66

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
1.24
1.62
1.08
1.32
1.51
Peer Median
2.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.74

Lower than Peers by 1.35

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
0.74
1.08
0.64
0.82
1.02
Peer Median
2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

11.64

Higher than Peers by 6.61

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
11.64
10.70
6.90
8.30
3.46
Peer Median
5.02
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

14.52

Lower than Peers by 2.09

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
14.52
14.58
15.27
15.65
15.53
Peer Median
16.61
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.43

Lower than Peers by 0.07

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
0.43
0.48
0.45
0.42
0.39
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
49.89
52.19
53.84
53.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
168.92
149.20
146.90
127.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
61.77
53.60
60.91
60.88
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
157.04
147.79
139.83
120.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

17.64

Lower than Peers by 28.41

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
17.64
49.42
71.79
53.60
95.62
Peer Median
46.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.59

Lower than Peers by 1.48

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
2.59
5.89
6.11
4.43
3.80
Peer Median
4.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

13.62

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
13.62
29.99
36.53
27.22
27.40
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

62,650

Higher than Peers by 62,140

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Boston Scientific Corp (BSX)
62,650
--
--
--
--
Peer Median
510
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...